This portal is intended for healthcare professionals (HCPs).
For any issues accessing Patient or HCP Hubs via this site, please clear your cookie history or try via your 'Incognito/Private' browser.
| PBS Information: Authority Required. This product is listed on the PBS as a Section 100 item. Refer to PBS Schedule for full authority information. |
This medicinal product is subject to additional monitoring in Australia. This will allow quick identification of new safety information.
Healthcare professionals are asked to report any suspected adverse events at www.tga.gov.au/reporting-problems.
PLEASE REVIEW PRODUCT INFORMATION BEFORE PRESCRIBING.
The Product Information can be accessad at https://rss.medsinfo.com.au/tb/pi.cfm?product=tbpradic or from Medical Information on
1800 AU TEVA (1800 28 8382) or by scanning the QR code. 
Teva Pharma Australia Pty Ltd ABN 41 169 715 664 Level 1, 37 Epping Road, Macquarie Park, NSW, 2113 Australia.
Phone: 1800 AU TEVA (1800 288 382)
www.tevapharma.com.au
Date of preparation: April 2025, RAD-AU-00020. Date of expiration: April 2027.
